Institutions / Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
CIK 1395064 · Institutionalso an insider · as of Sep 30, 2025takeda.com ↗
Portfolio value
$16.37M
Positions
8
As of
Sep 30, 2025
Portfolio trend
Portfolio value
$16.37M-16.3%Positions
8-27.3%Top holdings
Sep 30, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Ovid Therapeutics Inc.OVID | $9.79M | 59.8% |
| Equillium, Inc.EQ | $2.61M | 15.9% |
| Xilio Therapeutics, Inc.XLO | $1.24M | 7.6% |
| Shattuck Labs, Inc.STTK | $1.23M | 7.5% |
| Lyell Immunopharma, Inc.LYEL | $891.4K | 5.4% |
| American Well CorpAMWL | $478.1K | 2.9% |
| Rani Therapeutics Holdings, Inc.RANI | $101.6K | 0.6% |
| Standard Biotools Inc.FLDM | $21.5K | 0.1% |
Activity
Sep 30, 2025View full history →
InsidersInstitutions
This fund's quarter-over-quarter position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q3 2024 as of | Exit Other (per filing) | Denali Therapeutics Inc. common | $-97.86M | -4.2M -100.00% | 0 | high |
| Q1 2024 as of | Trim Other (per filing) | PHAT Phathom Pharmaceuticals, Inc. common | $-45.73M | -4.3M -57.73% | 3,153,217 204.57% of portfolio | medium |
| Q2 2024 as of | Trim Other (per filing) | PHAT Phathom Pharmaceuticals, Inc. common | $-16.44M | -1.6M -50.62% | 1,557,063 97.98% of portfolio | medium |
Insider transactions
Also trades as an insider
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 24, 2024 | Sell Open-market sale | PHAT Phathom Pharmaceuticals, Inc. Common Stock | $30.00M | -3.7M -49.65% | 3,755,583 4.64% of shares | high |
| Nov 4, 2021 | Sell Open-market sale | PHAT Phathom Pharmaceuticals, Inc. Common Stock | $20.85M | -1.0M -90.91% | 100,000 0.12% of shares | high |
| Sep 17, 2025 | Other Shares tendered | HLVX HilleVax, Inc. Common Stock | $13.11M | -6.7M -100.00% | 0 | low |